Ads

 

Ads

 

Ads

 

Top Pharmaceutical Companies in Europe List by Market Cap as on July-30-2023

Top Pharmaceutical Companies in Europe List by Market Cap as on July-30-2023. Biggest and Top Pharmaceutical Companies in Europe Companies by Market Cap. Largest Top Pharmaceutical Companies in Europe List by Market Cap as on July-30-2023.
Metatag Title
Top Pharmaceutical Companies in Europe
Metatag Abstract
Top Pharmaceutical Companies in Europe, Biggest Pharmaceutical Companies in Europe, Largest Pharmaceutical Companies in Europe.
  1. Argenx SE

    World Rank (Jan-05-2024)
    802
    Market Cap (Jan-05-2024)
    22.967 Billion USD
    World Rank (Jul-30-2023)
    621
    Market Cap (Jul-30-2023)
    30.537 Billion USD
    World Rank (Dec-25-2022)
    799
    Market Cap (Dec-25-2022)
    20.875 Billion USD
    World Rank (Jan-07-2022)
    1,257
    Market Cap (Jan-07-2022)
    16.13 Billion USD
    Annual Revenue in USD
    410 Million USD
    Annual Operating Income in USD
    -719 Million USD
    Annual Net Income in USD
    -709 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Biopharmaceutical company with headquarters is in Netherlands.

  2. Straumann Holding AG

    World Rank (Jan-05-2024)
    757
    Market Cap (Jan-05-2024)
    24.430 Billion USD
    World Rank (Jul-30-2023)
    712
    Market Cap (Jul-30-2023)
    26.251 Billion USD
    World Rank (Dec-25-2022)
    945
    Market Cap (Dec-25-2022)
    17.697 Billion USD
    World Rank (Jan-07-2022)
    669
    Market Cap (Jan-07-2022)
    31.43 Billion USD
    Annual Revenue in USD
    2,665 Million USD
    Annual Operating Income in USD
    609 Million USD
    Annual Net Income in USD
    499 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Manufactures and Markets Dental Implants, Biomaterials, Medical Equipment. Headquarters is in Basel, Switzerland.

  3. BioNTech SE

    World Rank (Jan-05-2024)
    686
    Market Cap (Jan-05-2024)
    26.909 Billion USD
    World Rank (Jul-30-2023)
    725
    Market Cap (Jul-30-2023)
    25.887 Billion USD
    World Rank (Dec-25-2022)
    380
    Market Cap (Dec-25-2022)
    42.705 Billion USD
    World Rank (Jan-07-2022)
    369
    Market Cap (Jan-07-2022)
    51.38 Billion USD
    Annual Revenue in USD
    19,085 Million USD
    Annual Operating Income in USD
    13,939 Million USD
    Annual Net Income in USD
    10,402 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    BIONTECH SE is biotechnology company with headquarters is in Germany.

  4. STERIS plc

    World Rank (Jan-05-2024)
    855
    Market Cap (Jan-05-2024)
    21.341 Billion USD
    World Rank (Jul-30-2023)
    826
    Market Cap (Jul-30-2023)
    22.694 Billion USD
    World Rank (Dec-25-2022)
    914
    Market Cap (Dec-25-2022)
    18.174 Billion USD
    World Rank (Jan-07-2022)
    891
    Market Cap (Jan-07-2022)
    23.49 Billion USD
    Annual Revenue in USD
    4,957 Million USD
    Annual Operating Income in USD
    759 Million USD
    Annual Net Income in USD
    107 Million USD
    Annual Results for Period Ending
    Mar-2023 ending year
    Headquarters Country
    Stock Category
    Company Profile

    STERIS is a leading provider of infection prevention and other procedural products and services. The company is focused primarily on healthcare, pharmaceutical and medical device Customers. Headquarters is in Dublin, Ireland.

  5. UCB SA

    World Rank (Jan-05-2024)
    1,055
    Market Cap (Jan-05-2024)
    16.926 Billion USD
    World Rank (Jul-30-2023)
    1,073
    Market Cap (Jul-30-2023)
    17.074 Billion USD
    World Rank (Dec-25-2022)
    1,081
    Market Cap (Dec-25-2022)
    15.163 Billion USD
    World Rank (Jan-07-2022)
    1,006
    Market Cap (Jan-07-2022)
    20.61 Billion USD
    Annual Revenue in USD
    6,083 Million USD
    Annual Operating Income in USD
    773 Million USD
    Annual Net Income in USD
    461 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile
    UCB is a global biopharmaceutical company focusing on creating value for people living with neurology and immunology conditions. Headquartered in Brussels, Belgium. As on 2019, UCB has Total revenue of 4.9 billion EUR and has more than 7,600 employees.
  6. bioMérieux S.A.

    World Rank (Jan-05-2024)
    1,355
    Market Cap (Jan-05-2024)
    12.841 Billion USD
    World Rank (Jul-30-2023)
    1,364
    Market Cap (Jul-30-2023)
    12.835 Billion USD
    World Rank (Dec-25-2022)
    1,305
    Market Cap (Dec-25-2022)
    12.163 Billion USD
    World Rank (Jan-07-2022)
    1,322
    Market Cap (Jan-07-2022)
    15.28 Billion USD
    Annual Revenue in USD
    3,957 Million USD
    Annual Operating Income in USD
    731 Million USD
    Annual Net Income in USD
    498 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Biotechnology company with headquarters is in France.

  7. Vifor Pharma AG

    World Rank (Jan-05-2024)
    1,412
    World Rank (Jul-30-2023)
    1,412
    Market Cap (Jul-30-2023)
    12.390 Billion USD
    World Rank (Dec-25-2022)
    1,365
    Market Cap (Dec-25-2022)
    11.553 Billion USD
    World Rank (Jan-07-2022)
    1,666
    Market Cap (Jan-07-2022)
    11.55 Billion USD
    Annual Revenue in USD
    1,865 Million USD
    Annual Net Income in USD
    153 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Stock Category
    Company Profile

    VIFOR PHARMA AG is Bio Pharmaceutical Company with headquarters is in Bern, Switzerland.

    CSL Limited announced in Dec-2021 that it is acquiring Vifor Pharma AG for 11.7 billion USD.

    Vifor Pharma Group net sales for Year 2019 grew to CHF 1,877.2 million, a strong increase of 18.5% compared to the previous year.

  8. Qiagen

    World Rank (Jan-05-2024)
    1,657
    Market Cap (Jan-05-2024)
    9.994 Billion USD
    World Rank (Jul-30-2023)
    1,592
    Market Cap (Jul-30-2023)
    10.745 Billion USD
    World Rank (Dec-25-2022)
    1,395
    Market Cap (Dec-25-2022)
    11.228 Billion USD
    World Rank (Jan-07-2022)
    1,676
    Market Cap (Jan-07-2022)
    11.46 Billion USD
    Annual Revenue in USD
    2,141 Million USD
    Annual Operating Income in USD
    576 Million USD
    Annual Net Income in USD
    423 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Pharmaceutical and research company with headquarters is in Germany.

  9. Recordati Industria Chimica E Farmaceutica

    World Rank (Jan-05-2024)
    1,524
    Market Cap (Jan-05-2024)
    10.987 Billion USD
    World Rank (Jul-30-2023)
    1,604
    Market Cap (Jul-30-2023)
    10.629 Billion USD
    World Rank (Dec-25-2022)
    1,742
    Market Cap (Dec-25-2022)
    8.558 Billion USD
    World Rank (Jan-07-2022)
    1,552
    Market Cap (Jan-07-2022)
    12.71 Billion USD
    Annual Revenue in USD
    2,043 Million USD
    Annual Operating Income in USD
    545 Million USD
    Annual Net Income in USD
    344 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Recordati Industria Chimica e Farmaceutica is a Pharmaceutical Multinational company. The company is a leader in the treatment of rare diseases and orphan drugs, has successfully implemented its strategy of establishing a direct presence in the main markets of all continents as per 2019. It is having more than 4,300 employees, which is dedicated to research, development, production and marketing of pharmaceutical products, consolidated revenues in 2019 were € 1,481.8 million, operating profit was € 465.3 million and net income was € 368.9 million. The headquarters is in Italy.

  10. Ipsen

    World Rank (Jan-05-2024)
    1,670
    Market Cap (Jan-05-2024)
    9.900 Billion USD
    World Rank (Jul-30-2023)
    1,617
    Market Cap (Jul-30-2023)
    10.484 Billion USD
    World Rank (Dec-25-2022)
    1,726
    Market Cap (Dec-25-2022)
    8.637 Billion USD
    World Rank (Jan-07-2022)
    2,325
    Market Cap (Jan-07-2022)
    7.70 Billion USD
    Annual Revenue in USD
    3,480 Million USD
    Annual Operating Income in USD
    960 Million USD
    Annual Net Income in USD
    714 Million USD
    Annual Results for Period Ending
    Dec-2022 ending year
    Headquarters Country
    Company Profile

    Ipsen is a global biopharmaceutical group dedicated to improving lives and health outcomes through innovative medicines in Oncology. Headquarters is in France.

Share

Ads